Media Resources

1 September

Mapping External Reference Pricing Practices for Medicines

14 July

Investor-State Dispute Settlement in EU-US Trade Deal Risks Access to Affordable Medicines

24 June

EMA’s New Policy on Access to Clinical Data – About to Privatise Pharmaceutical Knowledge?

3 April

Health Action International Welcomes Adoption of New Clinical Trials Regulation by European Parliament

3 April

Health Action International Applauds Medicines Patent Pool, ViiV Healthcare Licensing Agreement for New HIV Treatment

24 March

The EU-US Trade Agreement – Proposals by Pharmaceutical Industry Undermine European Public Policymaking and Public Health

17 March

EU Regulation on Clinical Trials – Close to the Finish Line

3 March

2013 Annual Report and Financial Statements

1 March

2013 Annual Report and Financial Statements

1 February

Working Paper 4 – Competition Policy

1 February

Policy Brief 3 – Regulation of Mark-ups in the Pharmaceutical Supply Chain

1 February

Policy Brief 5 – Sales Taxes on Medicines

1 February

Policy Brief 2 – The Role of Health Insurance in the Cost-effective Use of Medicines

1 February

Working Paper 1 – External Reference Pricing

1 February

Policy Brief 4 – Competition Policy

1 February

Policy Brief 1 – External Reference Pricing

1 February

Working Paper 2 – The Role of Health Insurance in the Cost-Effective Use of Medicines

1 February

Working Paper 3: The Regulation of Mark-ups in the Pharmaceutical Supply Chain

1 January

Understanding and Responding To Medicines Promotion

6 October

Transparency of Clinical Trial Data on Medicines in the EU

1 July

LAC-Global Alliance Statement on Trans-Pacific Partnership and Access to Affordable Medicines

21 June

NGOs Condemn the EU Press Release on TRIPS Extension for Least Developed Countries

16 April

Comprendre la promotion pharmaceutique et y répondre: Un manuel pratique

9 April

EU-India free trade deal puts millions of lives at risk

1 March

2012 Annual Report

1 March

2012 Financial Statements

16 July

ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies

8 June

Time for the final push: Say “No” to ACTA – again

15 May

EU Parliament Says No and No Again to EMA: Independent Groups Echo Decision

28 March

Big Pharma Spends Over €40 Million per Year Lobbying in the EU, Dwarfing Public Health NGOs